Navigation Links
National Jewish Health receives patent for liposome-based vaccine
Date:9/28/2010

National Jewish Health has received a US patent for a new kind of vaccine, which uses a small lipid bubble to deliver an antigen and DNA adjuvant. Chairman of Pediatrics Erwin Gelfand, MD, and former National Jewish Health Professor of Medicine Steve Dow, PhD, developed the new liposome-based adjuvant.

Live vaccines, containing weakened forms of an infectious organism, generally work fine by themselves. But vaccines containing dead organisms or pieces of the infectious organisms or their toxins generally need adjuvants to boost their effectiveness. Aluminum salts, known as alum, are the most common adjuvant used in the United States for routine preventive vaccines.

The recently patented invention by Drs. Gelfand and Dow describes a vaccine contained within a liposome, a tiny vesicle made of a double layer of lipids. Contained within the liposome is a DNA sequence that serves as an adjuvant. Depending on the sequence, either the DNA molecule itself or the protein for which it codes can be used to stimulate the immune system. This DNA molecule is fused to an immunogen, the protein fragment against which the immune mounts a specific attack. The protein fragment could be part of an infectious organism or possibly some other health hazard such as a cancer tumor. The liposome-based vaccine could be delivered either subcutaneously through injection or orally.


'/>"/>

Contact: William Allstetter
allstetterw@njhealth.org
303-398-1002
National Jewish Health
Source:Eurekalert

Page: 1

Related medicine news :

1. International Robotic Urology Symposium+2011
2. Medical profession needs special training to handle self-harm, says international review
3. International conference focusing on womens mental health Oct. 27 to 30 in Pittsburgh
4. Researcher wins $2.5 million award from National Institute on Drug Abuse
5. Rhode Island Hospital physician receives national award for research
6. U of M Masonic Cancer Center receives $26 million to lead national BMT cancer research
7. National Institute of General Medical Sciences chief wins prestigious public service award
8. Scott & White Healthcare to participate in international trial investigating lung cancer treatment
9. University of Houston researcher receives National Award of Excellence in Research
10. National study finds 70 percent increase in basketball-related traumatic brain injuries
11. Indianapolis to host international conference on frontotemporal dementias
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 08, 2016 , ... Launching of the ... Instance Manager architecture, meeting the needs of multichannel growth and doubling the ... auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, administrative flexibility ...
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ISLAND, N.Y., ... for adherence to the highest standards of trauma, maternity, cancer and chronic obstructive ... president and CEO, Dr. Daniel Messina. , Among the recognitions, the American College ...
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) 863, signed into law ... in 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition ... to the study, medical payments per claim in California decreased 4 percent in 2013 ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... the Affordable Care Act. Dr. Botelho advocates for the mass media launching of ... gives people ongoing opportunities to share their unfortunate experiences; such a movement can ...
(Date:12/8/2016)... AR (PRWEB) , ... December 08, 2016 , ... ... insurance and financial planning services from offices headquartered in Little Rock, has initiated ... Pantry. , According to the National Foundation to End Senior Hunger, Arkansas ranks ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016 CANTEL MEDICAL CORP. (NYSE: CMD ... $0.45 per diluted share, on a 22.1% increase in sales ... 31, 2016. This compares with net income of $14,254,000, or ... first quarter ended October 31, 2015. Non-GAAP ... 31, 2016 to $21,323,000, or $0.51 per diluted share, compared ...
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire/ ... with cutting edge next-generation sequencing and bioinformatics expertise; AITbiotech Pte ... the Genome Institute of Singapore (GIS) ... joint venture between Novogene and AITbiotech – will establish a ... Singapore .   The new centre will ...
(Date:12/7/2016)... --  IQuity, Inc., a specialty diagnostic technology ... has been appointed to its Board of ... experience as CEO, COO, and Board Director for ... the molecular, clinical diagnostic, and medical device industries. ... within the pharmaceutical industry. His operational and commercial ...
Breaking Medicine Technology: